References
- Bakshi R. Fatigue associated with multiple sclerosis: diagnosis, impact and management. Mult Scler. 2003;9:219–227. doi: https://doi.org/10.1191/1352458503ms904oa
- Wood B, van der Mei IA, Ponsonby AL, et al. Prevalence and concurrence of anxiety, depression and fatigue over time in multiple sclerosis. Mult Scler. 2013;19(2):217–224. doi:https://doi.org/10.1177/1352458512450351. PubMed PMID: 22729988.
- Vercoulen JHMM, Hommes OR, Swanink CMA, et al. The measurement of fatigue in patients with multiple sclerosis: a multidimensional comparison with patients with chronic fatigue syndrome and healthy subjects. Arch Neurol. 1996;53:642–649. doi: https://doi.org/10.1001/archneur.1996.00550070080014
- Smith MM, Arnett PA. Factors related to employment status changes in individuals with multiple sclerosis. Mult Scler. 2005;11:1–8. doi: https://doi.org/10.1191/1352458505ms1128ed
- Julian LJ, Vella L, Vollmer T, et al. Employment in multiple sclerosis. Exiting and re-entering the work force. J Neurol. 2008;255(9):1354–1360. doi:https://doi.org/10.1007/s00415-008-0910-y. PubMed PMID: 18677639; PubMed Central PMCID: PMCPMC3057081.
- Management of MS-related fatigue. New York: National Clinical Advisory Board of the National Multiple Sclerosis Society; 2006.
- Haas HL, Sergeeva OA, Selbach O. Histamine in the nervous system. Physiol Rev. 2008;88:1183–1241. doi:https://doi.org/10.1152/physrev.00043.2007.-Histamine doi: https://doi.org/10.1152/physrev.00043.2007
- Stahl SM. The pyschopharmacology of energy and fatigue. J Clin Psychiatry. 2002;63(1):7–8. doi: https://doi.org/10.4088/JCP.v63n0102
- Loy BD, O'Connor PJ. The effect of histamine on changes in mental energy and fatigue after a single bout of exercise. Physiol Behav. 2016;153:7–18. doi:https://doi.org/10.1016/j.physbeh.2015.10.016. PubMed PMID: 26482543.
- Haas H, Panula P. The role of histamine and the tuberomamillary nucleus in the nervous system. Nat Rev Neurosci. 2003;4(2):121–130. doi:https://doi.org/10.1038/nrn1034. PubMed PMID: 12563283.
- Yoshikawa T, Nakamura T, Shibakusa T, et al. Insufficient intake of L-histidine reduces brain histamine and causes anxiety-like behaviors in male mice. J Nutr. 2014;144(10):1637–1641. doi:https://doi.org/10.3945/jn.114.196105. PubMed PMID: 25056690.
- van Ruitenbeek P, Sambeth A, Vermeeren A, et al. Effects of L-histidine depletion and L-tyrosine/L-phenylalanine depletion on sensory and motor processes in healthy volunteers. Br J Pharmacol. 2009;157(1):92–103. doi:https://doi.org/10.1111/j.1476-5381.2009.00203.x. PubMed PMID: 19413574; PubMed Central PMCID: PMCPMC2697785.
- Yoshimatsu H, Chiba S, Tajima D, et al. Histidine suppresses food intake through its conversion into neuronal histamine. Exp Biol Med. 2002;227(1):63–68. doi: https://doi.org/10.1177/153537020222700111
- Sasahara I, Fujimura N, Nozawa Y, et al. The effect of histidine on mental fatigue and cognitive performance in subjects with high fatigue and sleep disruption scores. Physiol Behav. 2015;147:238–244. doi:https://doi.org/10.1016/j.physbeh.2015.04.042. PubMed PMID: 25921948.
- McDonald K, Trick L, Boyle J. Sedation and antihistamines: an update. Review of inter-drug differences using proportional impairment ratios. Hum Psychopharmacol. 2008;23(7):555–570. doi:https://doi.org/10.1002/hup.962. PubMed PMID: 18618902.
- Niu YC, Feng RN, Hou Y, et al. Histidine and arginine are associated with inflammation and oxidative stress in obese women. Br J Nutr. 2012;108(1):57–61. doi:https://doi.org/10.1017/S0007114511005289. PubMed PMID: 21996294.
- Watanabe M, Suliman ME, Qureshi AR, et al. Consequences of low plasma histidine in chronic kidney disease patients: associations with inflammation, oxidative stress, and mortality. Am J Clin Nutr. 2008;87:1860–1866. doi: https://doi.org/10.1093/ajcn/87.6.1860
- Feng RN, Niu YC, Sun XW, et al. Histidine supplementation improves insulin resistance through suppressed inflammation in obese women with the metabolic syndrome: a randomised controlled trial. Diabetologia. 2013;56(5):985–994. doi:https://doi.org/10.1007/s00125-013-2839-7 . PubMed PMID: 23361591.
- Teuscher C, Subramanian M, Noubade R, et al. Central histamine H3 receptor signaling negatively regulates susceptibility to autoimmune inflammatory disease of the CNS. Proc Natl Acad Sci USA. 2007;104(24):10146–10151. doi:https://doi.org/10.1073/pnas.0702291104. PubMed PMID: 17548817; PubMed Central PMCID: PMC1891222.
- Musio S, Gallo B, Scabeni S, et al. A key regulatory role for histamine in experimental autoimmune encephalomyelitis: disease exacerbation in histidine decarboxylase-deficient mice. J Immunol. 2006;176:17–26. doi: https://doi.org/10.4049/jimmunol.176.1.17
- Flachenecker P, Bihler I, Weber F, et al. Cytokine mRNA expression in patients with multiple sclerosis and fatigue. Mult Scler. 2004;10:165–169. doi: https://doi.org/10.1191/1352458504ms991oa
- Sitton NG, Dixon JS, Astbury C, et al. Kinetic investigations into the possible cause of low serum histidine in rheumatoid arthritis. Ann Rheum Dis. 1988;47:48–52. doi: https://doi.org/10.1136/ard.47.1.48
- Gerber DA. Low free serum histidine concentration in rheumatoid arthritis: a measure of disease activity. J Clin Invest. 1975;55:1164–1173. doi: https://doi.org/10.1172/JCI108033
- Dunstan R H, Sparkes DL, Macdonald MM, et al. Altered amino acid homeostasis and the development of fatigue by breast cancer radiotherapy patients: a pilot study. Clin Biochem. 2011;44(2-3):208–215. doi:https://doi.org/10.1016/j.clinbiochem.2010.10.002. PubMed PMID: 20950596.
- Mihalik SJ, Michaliszyn SF, Heras J, et al. Metabolomic profiling of fatty acid and amino acid metabolism in youth with obesity and type; 2, diabetes. Diabetes Care. 2012;35:605–611. doi: https://doi.org/10.2337/DC11-1577
- Yoshizawa M, Tashiro M, Fukudo S, et al. Increased brain histamine H1 receptor binding in patients with anorexia nervosa. Biol Psychiatry. 2009;65(4):329–335. doi:https://doi.org/10.1016/j.biopsych.2008.08.012. PubMed PMID: 18814859.
- Kasaoka S, Kawahara Y, Inoue S, et al. Gender effects in dietary histidine-induced anorexia. Nutrition. 2005;21(7–8):855–858. doi:https://doi.org/10.1016/j.nut.2004.12.009. PubMed PMID: 15975494.
- Gotoh K, Masaki T, Chiba S, et al. Hypothalamic neuronal histamine signaling in the estrogen deficiency-induced obesity. J Neurochem. 2009;110(6):1796–1805. doi:https://doi.org/10.1111/j.1471-4159.2009.06272.x. PubMed PMID: 19619143.
- McNair DM, Lorr M, Heuchert JWP, et al. Profile of mood states: brief form. North Tonawanda (NY): Multi-Health Systems (MHS); 2003.
- Krupp LB. Fatigue in multiple sclerosis: definition, pathophysiology and treatment. CNS Drugs. 2003;17(4):225–234. doi: https://doi.org/10.2165/00023210-200317040-00002
- Yeun EJ, Shin-Park KK. Verification of the profile of mood states-brief: cross-cultural analysis. J Clin Psychol. 2006;62(9):1173–1180. doi:https://doi.org/10.1002/jclp.20269. PubMed PMID: 16688705.
- Loy BD, O'Connor PJ, Dishman RK. The effect of a single bout of exercise on energy and fatigue states: a systematic review and meta-analysis. Fatigue Biomed Health Behav. 2013: 1–20. doi:https://doi.org/10.1080/21641846.2013.843266.
- Bakshi R, Shaikh ZA, Miletich RS, et al. Fatigue in multiple sclerosis and its relationship to depression and neurologic disability. Mult Scler. 2000;6:181–185. doi: https://doi.org/10.1177/135245850000600308
- Attarian HP, Brown KM, Duntley SP, et al. The relationship of sleep disturbances and fatigue in multiple sclerosis. Arch Neurol. 2004;61:525–528. doi: https://doi.org/10.1001/archneur.61.4.525
- Herring MP, Fleming KM, Hayes SP, et al. Moderators of exercise effects on depressive symptoms in multiple sclerosis: a meta-regression. Am J Prev Med. 2017;53(4):508–518. doi:https://doi.org/10.1016/j.amepre.2017.04.011. PubMed PMID: 28602542.
- Beck AT, Steer RA, Garbin MG. Psychometric properties of the beck depression inventory: twenty-five years of evaluation. Clin Psychol Rev. 1988;8:77–100. doi: https://doi.org/10.1016/0272-7358(88)90050-5
- Moran PJ, Mohr DC. The validity of Beck depression inventory and Hamilton rating scale for depression items in the assessment of depression among patients with multiple sclerosis. J Behav Med. 2005;28(1):35–41. doi:https://doi.org/10.1007/s10865-005-2561-0.
- Buysse DJ, Hall ML, Strollo PJ, et al. Relationships between the Pittsburgh Sleep Quality Index (PSQI), Epworth Sleepiness Scale (ESS), and clinical/polysomnographic measures in a community sample. J Clin Sleep Med. 2008; 4(6):563–571.
- Buysse DJ, Reynolds CF, Monk TH, et al. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193–213. doi: https://doi.org/10.1016/0165-1781(89)90047-4
- Carpenter JS, Andrykowski MA. Psychometric evaluation of the Pittsburgh Sleep Quality Index. J Psychosom Res. 1998;45(1):5–13. doi: https://doi.org/10.1016/S0022-3999(97)00298-5
- Godin G, Shephard RJ. A simple method to assess exercise behavior in the community. Can J Appl Sport Sci. 1985;10(3):141–146.
- Snook EM, Motl RW, Gliottoni RC. The effect of walking mobility on the measurement of physical activity using accelerometry in multiple sclerosis. Clin Rehabil. 2009;23:248–253. doi: https://doi.org/10.1177/0269215508101757
- Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33(11):1444–1452. doi: https://doi.org/10.1212/WNL.33.11.1444
- Bowen J, Gibbons L, Gianas A, et al. Self-administered expanded disability status scale with functional system scores correlates well with a physician-administered test. Mult Scler. 2001;7:201–206. doi: https://doi.org/10.1177/135245850100700311
- Fonteh AN, Harrington RJ, Harrington MG. Quantification of free amino acids and dipeptides using isotope dilution liquid chromatography and electrospray ionization tandem mass spectrometry. Amino Acids. 2007;32(2):203–212. doi:https://doi.org/10.1007/s00726-006-0370-6. PubMed PMID: 17031482.
- Phenomenex. Phenomenex EZ:faast [easy fast] amino acid sample testing kit (2003) user guide 4111 Madrid Avenue, Torrance, CA 90501-1430; 2003 . Available from: http://www.phenomenex.com.
- Iacobucci D, Posavac SS, Kardes FR, et al. Toward a more nuanced understanding of the statistical properties of a median split. J Consum Psychol. 2015;25(4):652–665. doi:https://doi.org/10.1016/j.jcps.2014.12.002.
- Hedges LV, Olkin I. Statistical methods for meta-analysis. New York: Academic Press; 1985.
- Cohen J. A power primer. Psychol Bull. 1992;112(1):155–159. doi: https://doi.org/10.1037/0033-2909.112.1.155
- Weaver B, Wuensch KL. SPSS and SAS programs for comparing Pearson correlations and OLS regression coefficients. Behav Res Methods. 2013;45(3):880–895. doi:https://doi.org/10.3758/s13428-012-0289-7. PubMed PMID: 23344734.
- Ballon JS, Feifel D. A systematic review of modafinil: potential clinical uses and mechanisms of action. J Clin Psychiatry. 2006;67:554–566. doi: https://doi.org/10.4088/JCP.v67n0406
- Horner WE, Johnson DE, Schmidt AW, et al. Methylphenidate and atomoxetine increase histamine release in rat prefrontal cortex. Eur J Pharmacol. 2007;558:96–97. doi:https://doi.org/10.1016/j.ejphar.2006.11.048.
- Bhargava P, Fitzgerald KC, Calabresi PA, et al. Metabolic alterations in multiple sclerosis and the impact of vitamin d supplementation. JCI Insight. 2017;2(19):e95302. doi:https://doi.org/10.1172/jci.insight.95302DS1 doi: https://doi.org/10.1172/jci.insight.95302
- Heesen C, Nawrath L, Reich C, et al. Fatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour? J Neurol Neurosurg Psychiatry. 2006;77(1):34–39. doi:https://doi.org/10.1136/jnnp.2005.065805. PubMed PMID: 16361589; PubMed Central PMCID: PMCPMC2117393.
- Mokhtarzade M, Ranjbar R, Majdinasab N, et al. Effect of aerobic interval training on serum IL-10, TNFalpha, and adipokines levels in women with multiple sclerosis: possible relations with fatigue and quality of life. Endocrine. 2017;57(2):262–271. doi:https://doi.org/10.1007/s12020-017-1337-y. PubMed PMID: 28616851.
- Morris G, Berk M, Walder K, et al. Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses. BMC Med. 2015;13:28. doi:https://doi.org/10.1186/s12916-014-0259-2. PubMed PMID: 25856766; PubMed Central PMCID: PMCPMC4320458.
- Regenold WT, Phatak P, Makley MJ, et al. Cerebrospinal fluid evidence of increased extra-mitochondrial glucose metabolism implicates mitochondrial dysfunction in multiple sclerosis disease progression. J Neurol Sci. 2008;275(1–2):106–112. doi:https://doi.org/10.1016/j.jns.2008.07.032. PubMed PMID: 18783801; PubMed Central PMCID: PMCPMC2584157.
- Amorini AM, Nociti V, Petzold A, et al. Serum lactate as a novel potential biomarker in multiple sclerosis. Biochim Biophys Acta. 2014;1842(7):1137–1143. doi:https://doi.org/10.1016/j.bbadis.2014.04.005. PubMed PMID: 24726946.
- Lazzarino G, Amorini AM, Petzold A, et al. Serum compounds of energy metabolism impairment are related to disability, disease course and neuroimaging in multiple sclerosis. Mol Neurobiol. 2017;54(9):7520–7533. doi:https://doi.org/10.1007/s12035-016-0257-9. PubMed PMID: 27826747.